BIOCEPT INC | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Biocept | 8-K: Current report
Biocept | 8-K: Current report
BIOCEPT INC | 8-K: Biocept Reports Second Quarter 2023 Financial Results
Biocept | 10-Q: Q2 2023 Earnings Report
Biocept | 8-K: Current report
Biocept | 3: Initial statement of beneficial ownership of securities-Officer Walsh Robert
Biocept | SC 13G: Statement of acquisition of beneficial ownership by individuals-Lind Global Fund II LP(9.9%),Lind Global Partners II LLC(9.9%), etc.
Biocept | 424B4: Prospectus
Biocept | EFFECT: Others
Biocept | CORRESP: CORRESP
Biocept | CORRESP: CORRESP
Biocept | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Biocept | CORRESP: CORRESP
Biocept | CORRESP: CORRESP
Biocept | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Biocept | CORRESP: CORRESP
Biocept | CORRESP: CORRESP
Biocept | CORRESP: CORRESP
Biocept | CORRESP: CORRESP
No Data
No Data